Akademik Veri Yönetim Sistemi
Cyprus Journal of Medical Sciences, cilt.10, sa.1, ss.60-64, 2025 (ESCI)
BACKGROUND/AIMS: Rapid diagnostic tests are designed to enable rapid diagnosis of infectious diseases, especially during outbreaks and pandemics. This study aims to retrospectively list the rapid antigen (Ag) tests used in the recent pandemic with the multi-criteria decision-making (MCDM) technique to evaluate the role of the MCDM technique in determining the most appropriate diagnostic techniques during a future outbreak. MATERIALS AND METHODS: Twenty-eight Ag diagnostic tests authorized for emergency use by the Food and Drug Administration during the coronavirus disease-2019 pandemic were retrospectively included. Limit of detection, positive and negative percent agreement, point-of-care test, sample type, test technique, Ag target, and result time were evaluated. The overall performance of the 28 Ag diagnostic tests was investigated using the fuzzy preference ranking organization method (F-PROMETHEE) of the MCDM approaches. RESULTS: According to the F-PROMETHEE analysis; clip coronavirus disease rapid ag test was ranked in first place, Sofia 2 Flu + severe acute respiratory syndrome (SARS) Ag fluorescent immunoassay, BD Veritor System, and VITROS Immunodiagnostic Products severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) test kits were ranked second, and third, respectively. The VITROS Immunodiagnostic Products SARS-CoV-2 Ag Reagent Pack was ranked last, due to the selected parameters in the ranking. CONCLUSION: The F-PROMETHEE method, one of the MCDM methods, can be applied to evaluate the tests used in the rapid diagnosis of pathogens, and can support clinicians and laboratories in choosing the most reliable and accurate diagnostic tests in future outbreaks and pandemics.